Cargando…

Triple negative breast cancer: the kiss of death

One of the most controversial women malignancies, triple negative breast cancers (TNBCs) are critically overviewed here, being focused on data useful in clinical practice or to improve the therapy and patients survival. TNBCs “choose” young women and its “kiss” is, unfortunately deadly in most cases...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jitariu, Adriana-Andreea, Cîmpean, Anca Maria, Ribatti, Domenico, Raica, Marius
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542300/ https://www.ncbi.nlm.nih.gov/pubmed/28445140 http://dx.doi.org/10.18632/oncotarget.16938

Ejemplares similares

Molecular Portrait of the Normal Human Breast Tissue and Its Influence on Breast Carcinogenesis
por: Margan, Madalin Marius, et al.
Publicado: (2016)

Endocrine Gland-Derived Vascular Endothelial Growth Factor/Prokineticin-1 in Cancer Development and Tumor Angiogenesis
por: Corlan, Ana Silvia, et al.
Publicado: (2017)

Platelet-derived growth factors induced lymphangiogenesis: evidence, unanswered questions and upcoming challenges
por: Jitariu, Andreea Adriana, et al.
Publicado: (2015)

New Approach to Rare Pediatric Multicystic Mesenteric Lymphangioma; Would It Guide the Development of Targeted Therapy?
por: Heredea, Rodica, et al.
Publicado: (2018)

Platelet-Derived Growth Factor (PDGF)/PDGF Receptors (PDGFR) Axis as Target for Antitumor and Antiangiogenic Therapy
por: Raica, Marius, et al.
Publicado: (2010)

Angiogenesis and Antiangiogenesis in Triple-Negative Breast cancer()
por: Ribatti, Domenico, et al.
Publicado: (2016)

The Multifaceted Role of Podoplanin Expression in Hepatocellular Carcinoma
por: Cioca, Andreea, et al.
Publicado: (2017)

DNA damage in human pterygium: One-shot multiple targets
por: Cimpean, Anca Maria, et al.
Publicado: (2013)

VEGF, VEGF165b and EG-VEGF expression is specifically related with hormone profile in pituitary adenomas
por: Corlan, Ana Silvia, et al.
Publicado: (2019)

Kiss of death
por: Leslie, Mitch
Publicado: (2001)

Mast Cells: Key Players in the Shadow in Oral Inflammation and in Squamous Cell Carcinoma of the Oral Cavity
por: Gaje, Pusa Nela, et al.
Publicado: (2016)

G protein-coupled KISS1 receptor is overexpressed in triple negative breast cancer and promotes drug resistance
por: Blake, Alexandra, et al.
Publicado: (2017)

Triple-negative breast cancer
por: Chacón, Reinaldo D, et al.
Publicado: (2010)

The matrix protein Fibulin-3 promotes KISS1R induced triple negative breast cancer cell invasion
por: Noonan, Michelle M., et al.
Publicado: (2018)

Geographic-Related Differences of Pituitary Adenomas Hormone Profile: Analysis of Two Groups Coming from Southeastern and Eastern Europe
por: Cimpean, Anca Maria, et al.
Publicado: (2015)

Hyaluronic Acid/Bone Substitute Complex Implanted on Chick Embryo Chorioallantoic Membrane Induces Osteoblastic Differentiation and Angiogenesis, but not Inflammation
por: Cirligeriu, Laura, et al.
Publicado: (2018)

ODP293 Aberant Expression of SF-1 Transcription Factor in ACTH-secreting Pituitary Tumors: Possible Association With Aggressive Disease Evolution
por: Nastase, Valeria, et al.
Publicado: (2022)

Kisspeptin/KISS1R System in Breast Cancer
por: Cvetković, Donna, et al.
Publicado: (2013)

Cisplatin Loaded Multiwalled Carbon Nanotubes Induce Resistance in Triple Negative Breast Cancer Cells
por: Badea, Madalina Andreea, et al.
Publicado: (2018)

Targeting TRAIL Death Receptors in Triple-Negative Breast Cancers: Challenges and Strategies for Cancer Therapy
por: Kundu, Manjari, et al.
Publicado: (2022)

Characteristics of triple-negative breast cancer
por: de Ruijter, Tim C., et al.
Publicado: (2010)

Immunotherapy for Triple-Negative Breast Cancer
por: Cao, Yifeng, et al.
Publicado: (2021)

Theranostics for Triple-Negative Breast Cancer
por: Choi, Hyeryeon, et al.
Publicado: (2023)

Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer
por: Sellitto, Assunta, et al.
Publicado: (2020)

Atrial fibrillation: A kiss of death?
por: de Boer, M. J.
Publicado: (2013)

Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications
por: Tierno, Domenico, et al.
Publicado: (2023)

Wnt signaling in triple-negative breast cancer
por: Pohl, SÖ-G, et al.
Publicado: (2017)

MicroRNAs and Triple Negative Breast Cancer
por: D’Ippolito, Elvira, et al.
Publicado: (2013)

Immunotherapeutic interventions of Triple Negative Breast Cancer
por: Li, Zehuan, et al.
Publicado: (2018)

Estrogen Actions in Triple-Negative Breast Cancer
por: Treeck, Oliver, et al.
Publicado: (2020)

Metabolic reprogramming in triple-negative breast cancer
por: Wang, Zhanyu, et al.
Publicado: (2020)

Immunotherapy Treatment for Triple Negative Breast Cancer
por: Berger, Elizabeth R., et al.
Publicado: (2021)

Drug Repurposing for Triple-Negative Breast Cancer
por: Ávalos-Moreno, Marta, et al.
Publicado: (2020)

Advances in immunotherapy for triple-negative breast cancer
por: Liu, Yang, et al.
Publicado: (2023)

Critical Analysis of Genome-Wide Association Studies: Triple Negative Breast Cancer Quae Exempli Causa
por: Jurj, Maria-Ancuta, et al.
Publicado: (2020)

Applications of CRISPR Technology to Breast Cancer and Triple Negative Breast Cancer Research
por: Pont, Mariona, et al.
Publicado: (2023)

Programmed cell death protein 1 is a marker for neoadjuvant chemotherapy response in triple-negative breast cancer
por: Gaui, Maria de Fátima Dias, et al.
Publicado: (2023)

Management Options in Triple-Negative Breast Cancer
por: Minami, Christina A., et al.
Publicado: (2011)

Molecular Classification of Triple-Negative Breast Cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2016)

Triple negative breast cancer: Pitfalls and progress
por: Zagami, Paola, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cajahjndug7n1tmo0voggeg9h4